Last reviewed · How we verify

NCT05295420

The Role of Platelet Rich Plasma Injections in Cases of Stress Incontinence

Completed NA Last updated 10 July 2023
What this trial tests

NA trial testing platelet rich plasma in Stress Urinary Incontinence in 20 participants. Completed in 30 June 2022.

Timeline
1 March 2022
Primary endpoint
15 June 2022
30 June 2022

Quick facts

Lead sponsorEgymedicalpedia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date1 March 2022
Primary completion15 June 2022
Estimated completion30 June 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Egymedicalpedia — full company profile →

Who can join

Adults 35 to 60, female only, with Stress Urinary Incontinence or Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Urinary incontinence can impact on one's social, physical, mental, and sexual wellbeing, and lead to depression and social isolation Stress urinary incontinence (SUI) refers to the involuntary leakage of urine accompanying physical exertion (i.e. coughing, exercise, and sneezing). It is commonly acquired after pregnancy and childbirth due to the weakening of the pelvic floor muscles that support the urethra against the anterior vaginal wall. Current SUI treatment includes surgery to re-establish sufficient urethral resistance in order to prevent urine leakage during increased intra-abdominal pressure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of platelet rich plasma

Trials testing the same drug.

Other recruiting trials for Stress Urinary Incontinence

Currently open trials in the same condition.

Other Egymedicalpedia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05295420.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing